Volume 22, Number 12—December 2016
Dispatch
Human Brucellosis in Febrile Patients Seeking Treatment at Remote Hospitals, Northeastern Kenya, 2014–2015
Table 1
Characteristic | No. (%) patients |
p value | Crude OR (95% CI) | |
---|---|---|---|---|
Positive for brucellosis, n = 146 |
Negative for brucellosis, n = 921 |
|||
Mean age, y, + SD |
34.8 + 11.5 |
33.9 + 12.6 |
0.863 |
NA |
Age group, y | ||||
<19 | 16 (11.0) | 127 (13.8) | NA | Referent |
20–29 | 31 (21.2) | 206 (22.4) | 0.418 | 1.29 (0.70–2.39) |
30–39 | 48 (32.9) | 265 (28.8) | 0.063 | 1.75 (0.97–3.08) |
40–49 | 38 (26.0) | 196 (21.3) | 0.169 | 1.52 (0.84–2.76) |
>50 |
13 (8.9) |
127 (13.8) |
0.764 |
0.90 (0.43–1.84) |
Male sex | 86 (58.9) | 401 (43.5) | 0.001 | 1.98 (1.30–2.68) |
Wajir County resident |
81 (55.5) |
440 (49.4) |
0.201 |
1.34 (0.97–1.77) |
Occupation | ||||
Herder | 109 (74.7) | 569 (61.8) | 0.002 | 3.81 (2.17–12.38) |
Civil servant | 16 (11.0) | 126 (13.7) | 0.199 | 2.53 (0.71–8.91) |
General business | 7 (4.8) | 67 (7.3) | 0.286 | 1.98 (0.49–7.85) |
Student | 6 (4.1) | 56 (6.1) | 0.308 | 2.08 (0.51–8.48) |
Livestock trader | 6 (4.1) | 53 (5.8) | 0.053 | 3.74 (0.98–14.26) |
Other |
2 (1.4) |
50 (5.4) |
NA |
Referent |
Education level | ||||
None | 98 (67.1) | 563 (61.1) | NA | Referent |
Primary | 25 (17.1) | 181 (19.7) | 0.335 | 0.79 (0.51–1.27) |
Secondary | 16 (11.0) | 104 (11.3) | 0.670 | 0.88 (0.69–1.56) |
Post-secondary |
7 (4.8) |
73 (7.9 |
0.146 |
0.56 (0.25–1.32) |
Somali ethnic group member |
133 (91.1) |
830 (90.1) |
0.712 |
1.12 (0.62–2.63) |
Clinical symptoms and signs | ||||
Headache | 113 (77.4) | 836 (90.8) | 0.504 | 1.45 (0.63–3.12) |
Chills | 93 (63.7) | 482 (52.3) | 0.065 | 1.79 (0.93–2.58) |
Arthralgia/myalgia | 118 (80.8) | 699 (75.9) | 0.322 | 1.48 (0.78–1.85) |
Malaise/fatigue | 101 (69.2) | 646 (70.1) | 0.018 | 2.20 (1.44–4.31) |
Anorexia | 63 (43.2) | 514 (55.8) | 0.610 | 0.91 (0.56–1.93) |
Respiratory tract infection | 34 (23.3) | 263 (28.6) | 0.434 | 1.03 (0.69–1.60) |
Constipation | 22 (15.1) | 171 (18.6) | 0.301 | 1.08 (0.83–3.11) |
Night sweats | 11 (7.5) | 159 (17.3) | 0.181 | 0.90 (0.67–5.90) |
Diarrhea | 8 (5.5) | 106 (11.5) | 0.120 | 0.95 (0.86–2.89) |
Weight loss | 12 (8.2) | 105 (11.4) | 0.228 | 1.24 (0.81- 6.04) |
Confusion† | 3 (2.3) | 42 (5.3) | 0.337 | 0.96 (0.60–2.91) |
Rash | 3 (2.1) | 40 (4.3) | 0.172 | 0.74 (0.22–1.55) |
Vomiting | 4 (2.7) | 28 (3.0) | 0.582 | 0.85 (0.36–1.98) |
Abdominal pain | 52 (35.6) | 215 (23.3) | 0.007 | 1.92 (1.35–5.64) |
Hepatomegaly/splenomegaly | 33 (22.6) | 103 (11.1) | 0.011 | 2.01 (1.63–8.10) |
History of fever, >14 d |
75 (51.4) |
326 (35.3) |
<0.001 |
3.71 (2.75–10.94) |
Provisional diagnosis‡ | ||||
Typhoid fever | 63 (43.2) | 371 (45.0) | 0.671 | NA |
Malaria | 30 (20.5) | 252 (30.5) | 0.079 | NA |
Pneumonia | 12 (8.2) | 114 (13.8) | 0.084 | NA |
Other§ |
14 (9.6) |
Undefined |
NA |
NA |
Days since fever onset/median | 24.5/16 | 13.0/8 | <0.001 | NA |
*NA, not available; OR, odds ratio.
†Data available for adult and adolescent patients only.
‡includes clinical diagnosis made by attending hospital clinician.
§Data not available for all patients.
Page created: November 18, 2016
Page updated: November 18, 2016
Page reviewed: November 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.